Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C412431-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $99.90 | |
C412431-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $299.90 | |
C412431-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $419.90 | |
C412431-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $721.90 | |
C412431-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,009.90 | |
C412431-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,413.90 |
Specifications & Purity | ≥97% |
---|---|
Biochemical and Physiological Mechanisms | Ca2+ channel agonist 1 is an agonist of\xa0N-type Ca2+\xa0channel\xa0and an inhibitor of\xa0Cdk2 with\xa0EC50 of 14.23 μM and 3.34 μM, respectively, Ca2+ channel agonist 1 is used as a potential treatment for motor nerve terminal dysfunction. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Product Description | Information Ca2+ channel agonist 1 is an agonist of N-type Ca2+ channel and an inhibitor of Cdk2 with EC50 of 14.23 μM and 3.34 μM, respectively, Ca2+ channel agonist 1 is used as a potential treatment for motor nerve terminal dysfunction. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (2R)-2-[[6-(benzylamino)-9-propylpurin-2-yl]amino]butan-1-ol |
---|---|
INCHI | InChI=1S/C19H26N6O/c1-3-10-25-13-21-16-17(20-11-14-8-6-5-7-9-14)23-19(24-18(16)25)22-15(4-2)12-26/h5-9,13,15,26H,3-4,10-12H2,1-2H3,(H2,20,22,23,24)/t15-/m1/s1 |
InChi Key | LKXPLOHGQSEPEM-OAHLLOKOSA-N |
Canonical SMILES | CCCN1C=NC2=C(N=C(N=C21)NC(CC)CO)NCC3=CC=CC=C3 |
Isomeric SMILES | CCCN1C=NC2=C(N=C(N=C21)N[C@H](CC)CO)NCC3=CC=CC=C3 |
PubChem CID | 69472592 |
Molecular Weight | 354.45 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
E2423244 | Certificate of Analysis | Jan 20, 2024 | C412431 |
E2423246 | Certificate of Analysis | Jan 20, 2024 | C412431 |
E2423248 | Certificate of Analysis | Jan 20, 2024 | C412431 |
E2423249 | Certificate of Analysis | Jan 20, 2024 | C412431 |
E2423251 | Certificate of Analysis | Jan 20, 2024 | C412431 |
E2423253 | Certificate of Analysis | Jan 20, 2024 | C412431 |
E2423255 | Certificate of Analysis | Jan 20, 2024 | C412431 |
E2423257 | Certificate of Analysis | Jan 20, 2024 | C412431 |
E2423258 | Certificate of Analysis | Jan 20, 2024 | C412431 |
E2423260 | Certificate of Analysis | Jan 20, 2024 | C412431 |
E2423262 | Certificate of Analysis | Jan 20, 2024 | C412431 |
E2423264 | Certificate of Analysis | Jan 20, 2024 | C412431 |